Cargando…
A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures
PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787743/ https://www.ncbi.nlm.nih.gov/pubmed/35076875 http://dx.doi.org/10.1007/s11916-022-01014-0 |
_version_ | 1784639421286449152 |
---|---|
author | Koushik, Sarang S. Schwartz, Ruben H. Cherkalin, Denis Sankar, Vignesh Shaparin, Naum Viswanath, Omar |
author_facet | Koushik, Sarang S. Schwartz, Ruben H. Cherkalin, Denis Sankar, Vignesh Shaparin, Naum Viswanath, Omar |
author_sort | Koushik, Sarang S. |
collection | PubMed |
description | PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression, neuropsychiatric disorders, peripheral vascular disease, and renal impairment, among others [1]. These confounding variables make the overall treatment of their pain condition much more challenging. RECENT FINDINGS: For patients requiring intravenous (IV) sedation for their pain procedures, the constant need for access may render them a “difficult stick” over time. Another factor to consider is the increasing requirements by the hospital system needing IV sedatives and analgesics in the intensive care unit and operating rooms during the coronavirus (COVID-19) pandemic. SUMMARY: Sublingual sufentanil (SST) provides an excellent analgesic option for patients undergoing interventional pain procedures. The use of SST allows hospitals to preserve IV agents for more critical areas and mitigates the difficulty of obtaining IV access in patients. |
format | Online Article Text |
id | pubmed-8787743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-87877432022-01-25 A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures Koushik, Sarang S. Schwartz, Ruben H. Cherkalin, Denis Sankar, Vignesh Shaparin, Naum Viswanath, Omar Curr Pain Headache Rep Chronic Pain Medicine (O Viswanath, Section Editor) PURPOSE OF REVIEW: Sedation for pain medicine procedures provides a unique challenge for proceduralists. Many patients dealing with pain are on chronic opioids and require higher doses of sedation for adequate procedural comfort. Chronic pain patients have various comorbidities including depression, neuropsychiatric disorders, peripheral vascular disease, and renal impairment, among others [1]. These confounding variables make the overall treatment of their pain condition much more challenging. RECENT FINDINGS: For patients requiring intravenous (IV) sedation for their pain procedures, the constant need for access may render them a “difficult stick” over time. Another factor to consider is the increasing requirements by the hospital system needing IV sedatives and analgesics in the intensive care unit and operating rooms during the coronavirus (COVID-19) pandemic. SUMMARY: Sublingual sufentanil (SST) provides an excellent analgesic option for patients undergoing interventional pain procedures. The use of SST allows hospitals to preserve IV agents for more critical areas and mitigates the difficulty of obtaining IV access in patients. Springer US 2022-01-25 2022 /pmc/articles/PMC8787743/ /pubmed/35076875 http://dx.doi.org/10.1007/s11916-022-01014-0 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Chronic Pain Medicine (O Viswanath, Section Editor) Koushik, Sarang S. Schwartz, Ruben H. Cherkalin, Denis Sankar, Vignesh Shaparin, Naum Viswanath, Omar A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title | A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title_full | A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title_fullStr | A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title_full_unstemmed | A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title_short | A Review of Sublingual Sufentanil Tablet (SST) and its Utility as an Analgesic Agent for Pain Procedures |
title_sort | review of sublingual sufentanil tablet (sst) and its utility as an analgesic agent for pain procedures |
topic | Chronic Pain Medicine (O Viswanath, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787743/ https://www.ncbi.nlm.nih.gov/pubmed/35076875 http://dx.doi.org/10.1007/s11916-022-01014-0 |
work_keys_str_mv | AT koushiksarangs areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT schwartzrubenh areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT cherkalindenis areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT sankarvignesh areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT shaparinnaum areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT viswanathomar areviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT koushiksarangs reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT schwartzrubenh reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT cherkalindenis reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT sankarvignesh reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT shaparinnaum reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures AT viswanathomar reviewofsublingualsufentaniltabletsstanditsutilityasananalgesicagentforpainprocedures |